ClinicalTrials.Veeva

Menu

Clinicopathological Importance of Colorectal Medullary Carcinoma: Retrospective Cohort Study

V

V.K.V. American Hospital, Istanbul

Status

Completed

Conditions

Colorectal Medullary Carcinoma

Study type

Observational

Funder types

Other

Identifiers

NCT03774862
VKVAmericanH

Details and patient eligibility

About

Medullary carcinoma (MC) is a rare tumor with solid growth pattern without glandular differentiation and constitute less than 1% of colorectal cancer. Lymph node positivity and distant organ metastasis were reported to be lower than other poorly differentiated adenocarcinomas. Therefore, the diagnosis of MC is pathologically important in terms of follow-up and treatment. MC is commonly localized in the right colon, has a large tumor size, and is mostly diagnosed in the T4 stage. As MC most likely have defects in DNA MMR, the correct pathological diagnosis is important for the postoperative treatment and the prognosis of the patients.

Full description

427 patients with colorectal cancer who were underwent surgery between January 2011 and December 2017, were evaluated retrospectively into 2 groups as MC (n:13) and non-MC (n:414) in terms of demographic characteristics, pathological data and oncological outcomes.

Enrollment

13 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • colorectal cancer diagnosis, medullary carcinoma

Exclusion criteria

  • none

Trial design

13 participants in 2 patient groups

Medullary carcinoma of colorectal cancers
non-medullary carcinomas of the colorectal cancers

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems